Apolipoprotein C-III: The Small Protein with Sizeable Vascular Risk
Date
2017Journal
Arteriosclerosis, Thrombosis, and Vascular BiologyPublisher
Lippincott Williams and WilkinsType
Article
Metadata
Show full item recordKeyword
apolipoprotein C-IIIcoronary artery disease
Editorials
hypertriglyceridemia
lipoprotein lipase
lipoproteins, VLDL
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019699233&doi=10.1161%2fATVBAHA.117.309493&partnerID=40&md5=5637da55fd7a942b4ad16ed71a433522; http://hdl.handle.net/10713/10017ae974a485f413a2113503eed53cd6c53
10.1161/ATVBAHA.117.309493
Scopus Count
Collections
Related articles
- Studies on the mechanism of hypertriglyceridemia in Tangier disease. Determination of plasma lipolytic activities, k1 values and apolipoprotein composition of the major lipoprotein density classes.
- Authors: Wang CS, Alaupovic P, Gregg RE, Brewer HB Jr
- Issue date: 1987 Jul 13
- Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
- Authors: Sun HY, Lin CC, Lee JC, Wang SW, Cheng PN, Wu IC, Chang TT, Lai MD, Shieh DB, Young KC
- Issue date: 2013 Aug
- Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism.
- Authors: Shirai K, Fitzharris TJ, Shinomiya M, Muntz HG, Harmony JA, Jackson RL, Quinn DM
- Issue date: 1983 Jun
- Metabolism of very-low-density lipoprotein and low-density lipoprotein containing apolipoprotein C-III and not other small apolipoproteins.
- Authors: Mendivil CO, Zheng C, Furtado J, Lel J, Sacks FM
- Issue date: 2010 Feb
- Genetic epistasis in the VLDL catabolic pathway is associated with deleterious variations on triglyceridemia in obese subjects.
- Authors: Brisson D, St-Pierre J, Santuré M, Hudson TJ, Després JP, Vohl MC, Gaudet D
- Issue date: 2007 Aug